Exchange: OTC·Updated 11:30 AM EST
About PAAFF
Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research segment. The Corporate and Research segment includes corporate overhead expenses. The company was founded on August 03, 2000 and is headquartered in Melbourne, Australia.